News

In a groundbreaking development that could herald a new era in the treatment of inherited deafness, a recent clinical trial ...
A man born with Usher syndrome type 1b, a rare genetic disease that causes congenital deafness and progressive blindness, has ...
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...
The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma ...
Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development ...
For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its ...
An expert discusses how clinics can successfully implement gene therapy workflows by establishing strong institutional protocols, assigning dedicated clinic coordinators, and using strategies like ...
Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
Local News Experimental Therapy Gives Children With Genetic Disorders A New Chance At Life March 24, 2019 / 7:09 PM PDT / CBS San Francisco by Juliette Goodrich and Molly McCrea ...
The first gene therapy product approved by the Food and Drug Administration (a treatment for a form of leukemia, approved last summer) costs hundreds of thousands of dollars for each infusion.